Showing 1 - 2 results of 2 for search 'Grazyna Pulka', query time: 0.01s Refine Results
  1. 1
    Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52

    Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52 by Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, Jan Brzezicki, Nataliya Reznichenko, Maria Agnieszka Zegadło-Mylik, Grazyna Pulka, Magdalena Dmowska-Stecewicz, Elżbieta Kłujszo, Dmytro Rekalov, Lidia Rajzer, Jiyoon Lee, Minkyung Lee, Young Hee Rho

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study

    Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study by Clive Grattan, Yevgeniya Dytyatkovska, Michał Springer, Maria Ratkova, Borislava Krusheva, Izabella Krupa‐Borek, Grazyna Pulka, Marta Chełmińska, Adam Reich, Sunghyun Kim, Yunju Bae, Suyoung Kim, Sewon Lee, Eunjin An, Jeong Eun Park, Jieun Ka, Jongho Kim, Sarbjit S. Saini

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: